Dear Valued Aspire Customers,
For those of you who are affected by FDA/TPD regulation guidelines, Aspire is working hard and making progress on both fronts.
Aspire is working to meet the FDA guidelines. We have retained a lawyer are working to register products and company. We will also be completing the ingredients listings which are due February 17, 2017.
As most of us know, in the USA, we will have at least two years to continue selling products that were already on the market before August 8, 2016.
Regarding the FDA’s PMTA process which will be due at the end of this two year period, Aspire will apply for as many products as we can. We do not have any specific number of products we will submit. We also do not have a specific time line.
The TPD November 20 deadline is approaching soon. Aspire is completing required TPD emissions and toxicology testing. The test results will confirm and ensure that Aspire vaping hardware is safe to use with E-liquids. TPD material submissions will only be provided to European governments via the submission portal. Some test results will also be required by the FDA and we will share the reports with the FDA when necessary.
Customers will not need to register to sell Aspire products for either TPD or FDA. Aspire will take all necessary steps to ensure you can continue reselling Aspire products as you have in the past. For this reason, we will not be releasing any files to the public.
We will have product registrations complete TPD by Mid-November. Please stay tuned to this blog as we will be releasing more FDA and TPD news.